Education and Training
Efficacy of Nitrous Oxide in OCD: Pilot Study
This study investigates whether the commonly used and well-tolerated inhaled anesthetic nitrous oxide can rapidly improve symptoms of OCD.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: Nitrous Oxide
- drug: Nitrogen
Eligibility
Inclusion Criteria:
- Age 18-65
- Primary diagnosis of OCD
- Sufficient severity of OCD symptoms
- Ability to tolerate a treatment-free period
- Capacity to provide informed consent
Exclusion Criteria:
- Psychiatric or medical conditions that make participation unsafe
- Pregnant or nursing females
- Concurrent use of any medications that might increase the risk of participation (e.g.
drug interactions)
Ages Eligible for Study
18 Years - 65 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Pavithra Makunda, MS
650-723-4095
I'm interested